Real-time enrollment status for this common variable immunodeficiency (cvid) clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 7:38 PM UTC
| NCT Number | NCT07284641 |
| Recruiting Status | Recruiting |
| Condition | Common Variable Immunodeficiency (CVID) |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Paul Szabolcs |
| Last Updated on CT.gov | May 15, 2026 (May 15, 2026) |
As of July 20, 2026: Clinical trial NCT07284641 is currently recruiting participants. This phase2 study for common variable immunodeficiency (cvid) is actively seeking new participants at 1 location across the United States. The study is sponsored by Paul Szabolcs. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07284641 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07284641 was last updated May 15, 2026 (May 15, 2026). HelloStudys verifies this status automatically.